Volume 70, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


To investigate the chronologic change of mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan, the presence of antibody to HTLV-I was tested in 4,187 healthy residents between, 4,528 nursery school children, and 3,837 pregnant women between 1968 and 2000. The chronologic change of the feeding method and the length of the breast-feeding period among 1,117 healthy mothers from 1937 to 1995 were also obtained by interview. Age-adjusted prevalence of HTLV-I among healthy residents decreased from 9.1% in 1968–1970 to 7.8% in 1981–1984 and to 6.3% in 1996–1998. The crude prevalence of antibody to HTLV-I among healthy residents less than 20 years old decreased significantly from 4.6% in 1968–1970 to 0.1% in 1996–1998 ( < 0.0001). The prevalence of antibody to HTLV-I among nursery school children decreased significantly over the study period, from a high of 1.8% in 1984 to a low of 0.2% in 1998 ( = 0.03). The prevalence among pregnant women decreased significantly from 5.6% in 1989–1992 to 3.7% in 1997–2000 ( = 0.0275). Prior to 1967, all healthy mothers breast-fed their children. After 1968, the use of bottled and mixed milk (breast milk and bottled milk) increased, with bottled milk becoming predominant after 1990 (89%). The percentage of healthy mothers breast-feeding for more than one year significantly decreased from 68.3% in 1937–1947 to 0.4% in 1990–1995 ( < 0.0001). Infection with HTLV-I in Okinawa has decreased mainly due to a reduction in the number of mothers breast-feeding and a shortening of the breast-feeding period. However, because the mother-to-child transmission rate among non-breast-feeders decreased from 12.8% in 1986–1991 to 3.2% in 1995–1999, there may be other factors involved in the decrease in mother-to-child transmission.


Article metrics loading...

Loading full text...

Full text loading...



  1. Yoshida M, Miyoshi I, Hinuma Y, 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79 : 2031–2035.
  2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2 : 407–410.
  3. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A, 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 2 : 117–122.
  4. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N, 1992. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83 : 236–239.
  5. Yamaguchi K, 1994. Human T-lymphotropic virus type I in Japan. Lancet 343 : 213–216.
  6. Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S, 1997. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Am J Trop Med Hyg 56 : 71–75.
  7. Asou N, Kumagai T, Uekihara S, Ishii M, Sato M, Sakai K, Nishimura H, Yamaguchi K, Takatsuki K, 1986. HTLV-I seroprevalence in patients with malignancy. Cancer 58 : 903–907.
  8. Tsuji Y, Doi H, Yamabe T, Ishimaru T, Miyamoto T, Hino S, 1990. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics 86 : 11–17.
  9. Hirata M, Hayashi J, Noguchi A, Nakashima K, Kajiyama W, Kashiwagi S, Sawada T, 1992. The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol 21 : 989–994.
  10. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J. Nomura H, Okochi K, 1986. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 154 : 851–857.
  11. Okochi K, Sato H, Hinuma Y, 1984. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 46 : 245–253.
  12. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA, 1992. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 51 : 886–891.
  13. Inaba S, Okochi K, Sato H, Fukada K, Kinukawa N, Nakata H, Kinjyo K, Fujii F, Maeda Y, 1999. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection. Transfusion 39 : 1104–1110.
  14. Cleghorn FR, Manns A, Falk R, Hartge P, Hanchard B, Jack N, Williams E, Jaffe E, White F, Bartholomew C, 1995. Effect of human T-lymphotropic virus type I infection on non-Hodgkin’s lymphoma incidence. J Natl Cancer Inst 87 : 1009–1014.
  15. Takatsuki K, Matsuoka M, Yamaguchi K, 1996. Adult T-cell leukemia in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 13 : S15–S19.
  16. Tajima K, 1990. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T-and B-cell Malignancy Study Group. Int J Cancer 45 : 237–243.
  17. Kajiyama W, Kashiwagi S, Hayashi J, Nomura H, Ikematsu H, Okochi K, 1986. Intrafamilial clustering of anti-ATLA-positive persons. Am J Epidemiol 124 : 800–806.
  18. Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M, 1983. An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 118 : 787–794.
  19. Ikematsu H, Kashiwagi S, Hayashi J, Nomura H, Kajiyama W, Tani S, Uragari Y, Goto M, 1987. A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan. Am J Epidemiol 126 : 50–54.
  20. Furusyo N, Hayashi J, Sawayama Y, Kishihara Y, Kashiwagi S, 1999. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg 60 : 616–622.
  21. Hayashi J, Yoshimura E, Nabeshima A, Kishihara Y, Ikematsu H, Hirata M, Maeda Y, Kashiwagi S, 1994. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa. Jpn J Gastroenterol 29 : 276–281.
  22. Shimizu C, Nabeshima S, Kikuchi K, Furusyo N, Kashiwagi S, Hayashi J, 2002. Prevalence of antibody to Chlamydia pneumoniae in residents of Japan, the Solomon Islands, and Nepal. Am J Trop Med Hyg 67 : 170–175.
  23. Hayashi J, Kashiwagi S, Nomura H, Kajiyama W, Ikematsu H, 1987. The control of hepatitis B virus infection with vaccine in Japanese nursery schools. Am J Epidemiol 126 : 474–479.
  24. Nakano S, Ando Y, Saito K, Moriyama I, Ichijo M, Toyama T, Sugamura K, Imai J, Hinuma Y, 1986. Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect 12 : 205–212.
  25. Kashiwagi S, Kajiyama W, Hayashi J, Noguchi A, Nakashima K, Nomura H, Ikematsu H, Sawada T, Kida S, Koide A, 1990. Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity. J Infect Dis 161 : 426–429.
  26. Blattner WA, Saxinger C, Riedel D, Hull B, Taylor G, Cleghorn F, Gallo R, Blumberg B, Bartholomew C, 1990. A study of HTLV-I and its associated risk factors in Trinidad and Tobago. J Acquir Immune Defic Syndr 3 : 1102–1108.
  27. Murphy EL, Figueroa JP, Gibbs WN: Holding-Cobham M, Cranston B, Malley K, Bodner AJ, Alexander SS, Blattner WA, 1991. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 133 : 1114–1124.
  28. Kishihara Y. Furusyo N. Kashiwagi K. Mitsutake A. Kashiwagi S. Hayashi J, 2001. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis 184 : 1114–1119.
  29. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S, 1993. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 137 : 43–48.
  30. Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D, Maloney EM, Blattner WA, 1997. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1 : 37–44.
  31. Takezaki T, Tajima K, Ito M, Ito S, Kinoshita K, Tachibana K, Matsushita Y, 1997. Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia 11 : S60–S62.
  32. Kawase K, Katamine S, Moriuchi R, Miyamoto T, Kubota K, Igarashi H, Doi H, Tsuji Y, Yamabe T, Hino S, 1992. Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res 83 : 968–977.
  33. Bittencourt AL, Sabino EC, Costa MC, Pedroso C, Moreira L, 2002. No evidence of vertical transmission of HTLV-I in bottle-fed children. Rev Inst Med Trop Sao Paulo 44 : 63–65.

Data & Media loading...

  • Received : 16 Jan 2003
  • Accepted : 12 Oct 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error